Cargando…
Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
Despite impressive clinical success, cancer immunotherapy based on immune checkpoint blockade remains ineffective in many patients due to tumoral resistance. Here we use the autochthonous TiRP melanoma model, which recapitulates the tumoral resistance signature observed in human melanomas. TiRP tumo...
Autores principales: | Zhu, Jingjing, Powis de Tenbossche, Céline G., Cané, Stefania, Colau, Didier, van Baren, Nicolas, Lurquin, Christophe, Schmitt-Verhulst, Anne-Marie, Liljeström, Peter, Uyttenhove, Catherine, Van den Eynde, Benoit J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680273/ https://www.ncbi.nlm.nih.gov/pubmed/29123081 http://dx.doi.org/10.1038/s41467-017-00784-1 |
Ejemplares similares
-
Epithelial-Mesenchymal-Transition-Like and TGFβ Pathways Associated with Autochthonous Inflammatory Melanoma Development in Mice
por: Wehbe, Maria, et al.
Publicado: (2012) -
TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism
por: Canè, Stefania, et al.
Publicado: (2021) -
Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression
por: Finisguerra, Veronica, et al.
Publicado: (2023) -
Tryptophan-Degrading Enzymes in Tumoral Immune Resistance
por: van Baren, Nicolas, et al.
Publicado: (2015) -
Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance
por: Vigneron, Nathalie, et al.
Publicado: (2015)